<--> SHORE-C: Sussex Health Outcomes Research and Education in Cancer

2022

Di Maio M, Basch E, Denis F, Fallowfield L J, Ganz P A, Howell D, Kowalski D, Perrone F, Stover A M, Sundaresan P, Warrington L, Zhang L, Apostolidis K, Freeman-Daily J, Ripamonti C I, Santini D, on behalf of the ESMO Guidelines Committeee The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline, Annals of Oncology, Published 21 April 2022

Amdal C D, Taylor K Kuliś D, Falk R S, Bottomley A, Arraras J I, Barte J H, Darlington A S, Hofsø K, Holzner B, Høyning Jørgensen N M, Mariano M P, Pe M, Piccinin C, Riccetti N, Schranz M, Wheelwright S, Bjordal K Health-related quality of life in patients with COVID-19; international development of a patient-reported outcome measure, Journal of Patient-Reported Outcomes, Published 26 March 2022

Fitzsimmons D, Wheelwright S Developing Cancer Quality of Life Assessment Tools, Handbook of Quality of Life in Cancer, Book Chapter, Published 26 March 2022

Glasspool R, Wheelwright S, Bolton V, Calman L, Cummings A, Elledge B, Foster R, Frankland J, Smith P, Stannard S, Turner J, Wright D, Foster C Modifiable pre-treatment factors are associated with quality of life in women with gynaecological cancers at diagnosis and one year later: Results from the HORIZONS UK national cohort study, Gynecologic Oncology, Published 26 March 2022

King L, Matthews S,Foster C, Starkings R, Holch P, Absolom K, Archer S,On behalf of the British Psychosocial Oncology Society Executive Committee A fascinating time to be involved with research’ Exploring the impact of COVID-19 on postgraduate psycho-oncology researchers, Psycho-Oncology, Published 19 January 2022

Fallowfield L J, Farewell D, Jones H, May S, Catt S, Starkings R, Jenkins V IMPARTER, Phase 1 of an intervention to improve patients’ understanding of gene expression profiling tests in breast cancer, Breast Cancer Research and Treatment, Published 04 January 2022

^ Top